当前位置: 首页 > 详情页

Association of polymorphisms in the LRP1 and A2M genes with Alzheimer's disease in the Northern Chinese Han population

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, 45 Changchun Street, Xuanwu District, Beijing 100053, China [2]Key Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China
出处:
ISSN:

关键词: Alzheimer's disease A2M LRP1 Polymorphism

摘要:
Low-density lipoprotein receptor-related protein1 (LRP1) and alpha-2-macroglobulin (A2M) are candidate genes for sporadic Alzheimer's disease (SAD). It is not clear whether the LRP1 exon 3 and A2M exon 24 polymorphisms are associated with SAD. In the present study, we used direct sequencing to genotype the LRP1 C766T (rs1799986) polymorphism in exon 3 and the A2M I1000V (rs669) polymorphism in exon 24 in 364 patients with SAD and 291 healthy control subjects from the Northern Chinese Han population. The distributions of LRP1 genotypes (chi-squared [chi(2)] = 7.25, degrees of freedom [d.f.] = 2, p = 0.027) and alleles (chi(2) = 8.154, d.f. = 1, p = 0.004) were significantly different between patients and controls who were apolipoprotein E (APOE) epsilon 4 positive. The T allele and TT+TC genotype were associated with a reduced risk of developing SAD (T allele: odds ratio [OR] = 0.541, 95% confidence interval [CI] = 0.368-0.859, p = 0.005; TT+TC genotype: OR = 0.613,95% CI = 0.315-0.725, p = 0.012). There was no statistically significant difference in allele and genotype frequencies between patients with SAD and control subjects for the A2M I1000V polymorphism, even after stratification by age of onset, gender, and APOE epsilon 4 status. We found an interaction between LRP1 and APOE genotypes (p = 0.001), but no interaction between LRP1 and A2M genotypes. Our results suggest that the T allele of the LRP1 C766T polymorphism is associated with a decreased risk of SAD in APOE epsilon 4 carriers from the Northern Han Chinese population. (C) 2012 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
JCR分区:
出版当年[2011]版:
Q4 NEUROSCIENCES Q4 CLINICAL NEUROLOGY
最新[2023]版:
Q3 CLINICAL NEUROLOGY Q4 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [1]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, 45 Changchun Street, Xuanwu District, Beijing 100053, China [2]Key Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China
通讯作者:
通讯机构: [1]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, 45 Changchun Street, Xuanwu District, Beijing 100053, China [2]Key Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院